These studies indicated that CMML is genetically heterogeneous with different pathways to a common disease phenotype, and CBL mutations may activate the RAS pathway and aberrant pSTAT5 activation in CMML. The gene discussed is CBL; the disease is chronic myelomonocytic leukemia.